As of 2025-10-16, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 14.1x | 11.0x |
| Forward P/E multiples | 10.6x - 16.3x | 12.4x |
| Fair Price | (13.20) - (16.56) | (14.30) |
| Upside | -169.5% - -187.1% | -175.2% |
| Date | EV/EBITDA |